Inflammatory mediators and intestinal injury

Clinics in Perinatology

Volumn 21, Issue 2, 1994, Pages 235-246

  Caplan, M S ^a   MacKendrick, W ^a  

^a EVANSTON HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

BACTERIAL INFECTION; DISEASE ASSOCIATION; ENTERIC FEEDING; HUMAN; HYPOXIA; INFANT; INTESTINE INJURY; MEDIATOR; NECROTIZING ENTEROCOLITIS; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0028352863     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-5108(18)30343-9     Document Type: Review

References (81)

1. Barber A.E. Coyle S.M. Marano M.A. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man J Immunol 150 1989 1999
2. Bautista A.P. Spitzer J.J. Platelet activating factor stimulates and primes the liver, kupffer cells and neutrophils to release superoxide anion Free Radic Res Commun 17 1992 195
3. Bemat A. Herbert J.M. Salel V. Protective effect of SR-27417, anovelPAF antagonist, on PAF-induced or endotoxin-induced hypotension in the rat and the guinea-pig J Lipid Mediat 5 1992 41
4. Beutler B. Cerami A. Cachectin: More than a tumor necrosis factor N Engl J Med 316 1987 379
5. Blank M.L. Lee T.C. Fitzgerald V. A specific acetylhydrolase for l-alkyl-2-acetyl-sn glycero-3-phosphocholine (a hypotensive and platelet-activating lipid) J Biol Chem 256 1981 175
6. 2 biosynthesis in endotoxin-induced intestinal damage in the rat Prostaglandins 38 1989 320
7. Bussolino F. Breviario F. Tetta C. Interleukin-1 stimulates platelet-activating factor production in cultured human endothelial cells J Clin Invest 77 1986 2027
8. Bussolino F. Camussi G. Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin-1 J Biol Chem 263 1988 11856
9. Camussi G. Bussolino F. Salvidio G. Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor J Exp Med 166 1987 1390
10. Caplan M.S. Adler L. Kelly A. Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells Biochim Biophys Acta 1128 1992 205
11. Caplan M. Hsueh W. Kelly A. Serum PAF acetylhydrolase increases during neonatal maturation Prostaglandins 39 1990 705
12. Caplan M.S. Kelly A. Hsueh W. Endotoxin and hypoxia-induced intestinal necrosis in rats: the role of platelet activating factor Pediatr Res 31 1992 428
13. Caplan M.S. Sun X.M. Hsueh W. Hypoxia, PAF, and necrotizing enterocolitis Lipids 26 1991 1340
14. Caplan M.S. Sun X.M. Hsueh W. Hypoxia causes ischemic bowel necrosis in rats: The role of platelet-activating factor (PAF-acether) Gastroenterology 99 1990 979
15. Caplan M.S. Sun X.M. Hsueh W. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis J Pediatr 116 1990 960
16. Chang S.W. Feddersen C.O. Henson P.M. Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats J Clin Invest 79 1987 1498
17. Cueva J.P. Hsueh W. Role of oxygen derived free radicals in platelet activating factor induced bowel necrosis Gut 29 1988 1207
18. Denizot Y. Raibaud P. Ducluzeau R. Modulation of gut wall PAF-acether and precursors by intestinal microflora Res Immunol 141 1990 235
19. Denizot Y. Sobhani I. Rambaud J.C. PAF-acether synthesis by Helicobacter pylori Gut 31 1990 1242
20. Doebber T.W. Wu M.S. Robbins J.C. Platelet-activating factor (PAF) involvement in endotoxin-induced hypotension in rats: Studies with PAF-receptor antagonist kadsuren one Biochem Biophys Res Commun 127 1985 799
21. Ekblad H. Arjamaa O. Vuolteenaho O. Plasma endothelin-1 concentrations at different ages during infancy and childhood Acta Paediatr 82 1993 302
22. Elton T.S. Oparil S. Taylor G.R. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat Am J Physiol 263 1992 R1260
23. Farr R.S. Wardlow M.L. Cox C.P. Human serum add-labile factor is an acetylhydrolase that inactivates platelet-activating factor Fed Proc 42 1983 3120
24. Filep J.G. Braquet P. Mozes T. Interactions between platelet-activating factor and prostanoids during mesenteric ischemia-reperfusion-induced shock in the anesthetized dog Circ Shock 35 1991 1
25. Giers G. Janzarik H. Kempe E.R. PAF-acether-antagonist WEB 2086 for treatment of chronic idiopathic thrombocytopenia Lancet 336 1990 191
26. Gonzalez-Crussi F. Hsueh W. Experimental model of ischemic bowel necrosis: The role of platelet-activating factor and endotoxin Am J Pathol 112 1983 127
27. Goppeltstruebe M. Rehfeldt W. Glucocorticoids inhibit TNF alpha-induced cytosolic phospholipase A2 activity Biochim Biophys Acta 1127 1992 163
28. Hanahan D.J. Platelet activating factor: A biologically active phosphoglyceride Ann Rev Biochem 55 1986 483
29. Handley D.A. Tomesch J.C. Saunders R.N. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog and primate by the receptor antagonist SRI 63-441 Thromb Haemost 56 1986 40
30. Hayes J.P. Ridge S.M. Griffith S. Inhibition of cutaneous and platelet responses to platelet-activating factor by oral WEB 2086 in man J Allergy Clin Immunol 88 1991 83
31. Hieda H.S. Gomez-Sanchez C.E. Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not Life Sci 47 1990 247
32. Horio T. Kohno M. Yokokawa K. Effect of hypoxia on plasma immunoreactive endothelin-1 concentration in anesthetized rats Metabolism 40 1990 999
33. Hsueh W. Gonzalez-Crussi F. Ischemic bowel necrosis induced by platelet-activating factor: An experimental model Methods Achiev Exp Pathol 13 1988 208
34. Hsueh W. Gonzalez-Crussi F. Arroyave J. Platelet activating factor-induced ischemic bowel necrosis: The effect of PAF antagonists Eur J Pharmacol 123 1986 79
35. Hsueh W. Gonzalez-Crussi F. Arroyave J.L. Platelet-activating factor-induced ischemic bowel necrosis: An investigation of secondary mediators in its pathogenesis Am J Pathol 122 1986 231
36. Hsueh W. Gonzalez-Crussi F. Arroyave J.L. Platelet-activating factor: An endogenous mediator for bowel necrosis in endotoxemia FASEB J 1 1987 403
37. 4 by isolated, perfused rat small intestine in response to platelet-activating factor J Clin Invest 78 1986 108
38. Hsueh W. Gonzalez-Crussi F. Arroyave J.L. Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor Gastroenterology 94 1988 1412
39. Isozaki-Fukuda Y. Kojima T. Hirata Y. Plasma immunoreactive endothelin-1 concentration in human fetal blood: Its relation to asphyxia Pediatr Res 30 1991 244
40. Israel E.J. Schiffrin E.J. Carter E.A. Prevention of necrotizing enterocolitis in the rat with prenatal cortizone Gastroenterology 99 1990 1333
41. Kato M. Tokuyama K. Morikawa A. Platelet-act superoxide anion generation in guinea-pigs Eur J Pharmacol 232 1993 7
42. Kliegman R.M. Fanaroff A.A. Necrotizing enterocolitis N Engl J Med 310 1984 1093
43. Klosterhalfen B. Horstmannjungemann K. Vogel P. Time course of various inflammatory mediators during recurrent endotoxemia Biochem Pharmacol 43 1992 2103
44. Kojima T. Isozakifukuda Y. Takedatsu M. Plasma endothelin-1 like immunoreactivity levels in neonates Eur J Pediatr 151 1992 913
45. Kourembanas S. Marsden P.A. Mcquillan L.P. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium J Clin Invest 88 1991 1054
46. Koyama H. Nishzawa Y. Morii H. Plasma endothelin levels in patients with uraemia Lancet ii 1989 991
47. Kubes P. Arfors K.E. Granger D.N. Platelet-activating factor-induced mucosal dysfunction—role of oxidants and granulocytes Am J Physiol 260 1991 G965
48. Kubes P. Ibbotson G. Russell J. Role of platelet-activating factor in ischemia/reperfusion-induced leukocyte adherence Am J Physiol 259 1990 G300
49. Llausas-Magana E. Hsueh W. Arroyave C.M. Cobra venom factor, an activator of the complement system, enhances the bowel necrosis induced by platelet-activating factor Immunopharmacology 15 1988 31
50. MacKendrick W. Hill N. Hsueh W. Increase in plasma platelet activating factor levels in enterally fed preterm infants Biol Neonate 64 1993 89
51. MacKendrick W. Caplan M. Hsueh W. Endogenous nitric oxide protects against platelet activating factor-induced bowel injury in the rat Pediatr Res 34 1993 222
52. McIntyre T.M. Zimmerman G.A. Satoh K. Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate J Clin Invest 76 1985 271
53. McIntyre T.M. Zimmerman G.A. Prescott S.M. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils Proc Natl Acad Sci USA 83 1986 2204
54. Miller M.J.S. McNeill H. Mullane K.M. SOD prevents damage and attenuates eicosan oid release in a rabbit model of necrotizing enterocolitis Am J Physiol 255 1988 G556
55. Miura S. Kurose I. Fukumura D. Ischemic bowel necrosis induced by endothelin-1: An experimental model in rats Digestion 48 1991 163
56. Mozes T. Braquet P. Filep J. Platelet-activating factor: An endogenous mediator of mesenteric ischemia-reperfusion-induced shock Am J Physiol 257 1989 R872
57. Musameche C. Caplan M. Hsueh W. Experimental necrotizing enterocolitis: The role of polymorphonuclear neutrophils J Pediatr Surg 26 1991 1047
58. Nowicki P.T. Miller C.E. Edwards R.C. Effects of hypoxia and ischemia on autoregulation in postnatal intestine Am J Physiol 261 1991 G152
59. Prescott S.M. Zimmerman G.A. McIntyre T.M. Human endothelial cells in culture produce platelet-activating factor (l-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin Proc Natl Acad Sci USA 81 1984 3534
60. Prevost M.C. Cariven C. Simon M.F. Platelet activating factor (PAF-acether) is released into rat pulmonary alveolar fluid as a consequence of hypoxia Biochem Biophys Res Commun 119 1984 58
61. Rabinovici R. Yeh C.G. Hillegass L.M. Role of complement in endotoxin/platelet-activating factor-induced lung injury J Immunol 149 1992 1744
62. Rolapleszczynski M. Stankova J. Differentiation-dependent modulation of TNF production by PAF in human HL-60 myeloid leukemia cells J Leukoc Biol 51 1992 609
63. Rubanyi G.M. Botelho L.H.P. Endothelins FASEB J 5 1991 2713
64. Ryder R.W. Shelton J.D. Guinan M.E. Necrotizing enterocolitis Am J Epidemiol 112 1980 113
65. Scheifele D.W. Olsen E. Fussell S. Spontaneous endotoxinemia in premature infants: Correlations with oral feeding and bowel dysfunction J Pediatr Gastroenterol 4 1985 67
66. Sun X.M. Hsueh W. Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor J Clin Invest 81 1988 1328
67. Sun X.M. Hsueh W. Platelet-activating factor produces shock, in vivo complement activation, and tissue injury in mice J Immunol 147 1991 509
68. Suttorp N. Buerke M. Tannertotto S. Stimulation of PAF-synthesis in pulmonary artery endothelial cells by Staphylococcus-aureus alpha-toxin Thromb Res 67 1992 243
69. Takayasu M. Kondo K. Terao S. Endothelin-induced mobilization of CA and the possible involvement of platelet activating factor and thromboxane A2 Biochem Biophys Res Commun 160 1989 751
70. 4 biosynthesis in human neutrophils Biochem Pharmacol 38 1989 2559
71. Terashita Z. Shibouta Y. Imura Y. Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF) Life Sci 45 1989 1911
72. Touloukian R.J. Posch J.N. Spencer R. The pathogenesis of ischemic gastroenterocolitis of the neonate: Selective gut mucosal ischemia in asphyxiated neonatal piglets J Pediatr Surg 7 1972 194
73. Tracey K.J. Beutler B. Lowry S.F. Shock and tissue injury induced by recombinant human cachectin Science 234 1986 470
74. Valone F.H. Ruis N.M. Stimulation of tumour necrosis factor release by cytotoxic analogues of platelet-activating factor Immunology 76 1992 24
75. Wallace J.L. Steel G. Whittle B.J.R. Evidence for platelet-activating factor as a mediator of endotoxin-induced gastrointestinal damage in the rat: Effects of three platelet-activating factor antagonists Gastroenterology 93 1987 765
76. Walsh M.C. Kliegman R.M. Necrotizing enterocolitis: Treatment based on staging criteria Pediatr Clin North Am 33 1986 179
77. Whatley R.E. Zimmerman G.A. McIntyre T.M. Production of platelet activating factor by endothelial cells Semin Thromb Hemost 13 1987 445
78. Whittle B.J.R. Boughton-Smith N.K. Hutcheson I.R. Increased intestinal formation of PAF in endotoxin-induced damage in the rat Br J Pharmacol 92 1987 3
79. Wirthmueller U. De Weck A.L. Dahinden C.A. Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylala nine J Immunol 142 1989 3213
80. Yanagisawa M. Kurihara H. Kimura S. A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 332 1988 411
81. Zimmerman G.A. McIntyre T.M. Prescott S.M. Production of platelet-activating factor by human vascular endothelial cells: Evidence for a requirement for specific agonists and modulation by prostacyclin Circulation 72 1985 718